Join the Campaign

APhA releases zoster vaccine comparison chart

New tool helps keep pharmacists up to date on new and current vaccines

Pharmacists and other immunization providers should understand key differences between currently available herpes zoster vaccines: Shringrix (GlaxoSmithKline) and Zostavax (Merck). APhA has developed a one-page reference PDF for providers to post in their practices.

The document provides information at a glance about storage (freezer vs. refrigerator), vaccine type, route of administration (I.M. vs. subcutaneous), dosing intervals, age of patient recommended to receive the vaccine, contraindications, adverse effects, and concomitant administration.

“Practice changes based on available evidence and new products. It’s important to keep up with changing immunization guidelines,” said APhA Chief Strategy Officer Mitchel C. Rothholz, RPh, MBA. “APhA’s resources help you stay on the cutting edge with current recommendations and new product introduction.”

To access and download the PDF, visit pharmacist.com.

For more information, APhA members can sign up at no charge for the Immunizing Pharmacists News Mailing List and ACIP Immunization Update webinars.

Ad Position: 
Bottom Center Aligned
  • Join the Campaign
  • Take Action ALT Text
  • Get the facts ALT text
LATEST NEWS
October 17, 2017
October 17, 2017
APhA Executive Vice President and CEO Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA, testified in a hearing about drug prices held by the...
Gag clauses, lack of provider status hinder cost-effective care, importation is no solution, APhA CEO says
MORE
August 14, 2017
August 14, 2017
Tennessee saw major provider status legislation take effect on July 1. “Pharmacists as Providers” (HB 405/SB 461) gives Tennessee pharmacists formal...
‘Pharmacists as providers’ legislation went into effect July 1
MORE
July 13, 2017
July 13, 2017
The Massachusetts Senate and House of Representatives health care committee held a hearing on legislation that would expand the scope of practice...
Hearing held last month included testimony from pharmacists and physicians
MORE
Advertisement